🇺🇸 FDA
Patent

US 10912741

Prevention of liver cancer with safranal-based formulations

granted A61KA61K31/11A61P

Quick answer

US patent 10912741 (Prevention of liver cancer with safranal-based formulations) held by UNITED ARAB EMIRATES UNIVERSITY expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED ARAB EMIRATES UNIVERSITY
Grant date
Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/11, A61P, A61P35/00